Reflow And MicroPort Scientific Announce Chinese Alliance
SAN CLEMENTE, Calif. & SHANGHAI--(BUSINESS WIRE)--ReFlow Medical, Inc. (ReFlow) today announced that it has signed an exclusive distribution and sales agreement for ReFlow's suite of peripheral chronic total occlusion (CTO) products with MicroPort Endovascular (MicroPort Endo), a division of MicroPort Scientific Corporation (MicroPort), a leading medical device company in China.
Help employers find you! Check out all the jobs and post your resume.